Literature DB >> 11729304

Lysophospholipids--receptor revelations.

T Hla1, M J Lee, N Ancellin, J H Paik, M J Kluk.   

Abstract

Upon cell activation, membrane phospholipids are metabolized into potent lysophospholipid (LP) mediators, such as sphingosine 1-phosphate and lysophosphatidic acid. LPs fulfill signaling roles in organisms as diverse as yeast and humans. The recent discovery of G protein-coupled receptors for LPs in higher eukaryotes, and their involvement in regulating diverse processes such as angiogenesis, cardiac development, neuronal survival, and immunity, has stimulated growing interest in these lipid mediators. LP receptor biology has generated insights into fundamental cellular mechanisms and may provide therapeutic targets for drug development.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11729304     DOI: 10.1126/science.1065323

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  119 in total

Review 1.  Lipoatrophic diabetes and other related syndromes.

Authors:  Elif Arioglu Oral
Journal:  Rev Endocr Metab Disord       Date:  2003-03       Impact factor: 6.514

Review 2.  The therapeutic potential of modulating the ceramide/sphingomyelin pathway.

Authors:  Richard Kolesnick
Journal:  J Clin Invest       Date:  2002-07       Impact factor: 14.808

3.  Rapid induction of medullary thymocyte phenotypic maturation and egress inhibition by nanomolar sphingosine 1-phosphate receptor agonist.

Authors:  Hugh Rosen; Christopher Alfonso; Charles D Surh; Michael G McHeyzer-Williams
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-03       Impact factor: 11.205

Review 4.  The role of cholesterol efflux in regulating the fertilization potential of mammalian spermatozoa.

Authors:  Alexander J Travis; Gregory S Kopf
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

5.  Sphingosine 1-phosphate activates Weibel-Palade body exocytosis.

Authors:  Kenji Matsushita; Craig N Morrell; Charles J Lowenstein
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-23       Impact factor: 11.205

6.  FTY720 markedly increases alloengraftment but does not eliminate host anti-donor T cells that cause graft rejection on its withdrawal.

Authors:  Patricia A Taylor; Ryan M Kelly; Nick D Bade; Michelle J Smith; Heather E Stefanski; Bruce R Blazar
Journal:  Biol Blood Marrow Transplant       Date:  2012-06-19       Impact factor: 5.742

7.  Asymmetric synthesis of conformationally constrained fingolimod analogues--discovery of an orally active sphingosine 1-phosphate receptor type-1 agonist and receptor type-3 antagonist.

Authors:  Ran Zhu; Ashley H Snyder; Yugesh Kharel; Lisa Schaffter; Qin Sun; Perry C Kennedy; Kevin R Lynch; Timothy L Macdonald
Journal:  J Med Chem       Date:  2007-11-10       Impact factor: 7.446

8.  Regulation of autophagy and its associated cell death by "sphingolipid rheostat": reciprocal role of ceramide and sphingosine 1-phosphate in the mammalian target of rapamycin pathway.

Authors:  Makoto Taniguchi; Kazuyuki Kitatani; Tadakazu Kondo; Mayumi Hashimoto-Nishimura; Satoshi Asano; Akira Hayashi; Susumu Mitsutake; Yasuyuki Igarashi; Hisanori Umehara; Hiroyuki Takeya; Junzo Kigawa; Toshiro Okazaki
Journal:  J Biol Chem       Date:  2012-10-03       Impact factor: 5.157

Review 9.  Sphingosine-1-phosphate and modulation of vascular tone.

Authors:  Junsuke Igarashi; Thomas Michel
Journal:  Cardiovasc Res       Date:  2009-02-20       Impact factor: 10.787

Review 10.  Cellular signaling and NO production.

Authors:  Thomas Michel; Paul M Vanhoutte
Journal:  Pflugers Arch       Date:  2010-01-16       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.